2004
DOI: 10.1074/jbc.m409848200
|View full text |Cite
|
Sign up to set email alerts
|

ATP-binding Cassette Transporter A1 Contains a Novel C-terminal VFVNFA Motif That Is Required for Its Cholesterol Efflux and ApoA-I Binding Activities

Abstract: The stimulation of cellular cholesterol and phospholipid efflux by apolipoprotein A-I is mediated by the activity of the ATP-binding cassette transporter A1 (ABCA1). Individuals with Tangier disease harbor lossof-function mutations in this transporter that have proven useful in illuminating its activity. Here, we analyze a mutation that deletes the last 46 residues of the 2261 amino acid transporter (⌬46) and eliminates its lipid efflux. As the final four amino acids of the C terminus represent a putative PDZ-… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

4
63
0

Year Published

2006
2006
2020
2020

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 66 publications
(67 citation statements)
references
References 43 publications
4
63
0
Order By: Relevance
“…The C-terminal VFVNFA motif of ABCA1 has been shown to be essential for its lipid efflux activity. Alteration of this motif did not prevent trafficking of the transporter to the plasma membrane, but did eliminate apoA-I binding to ABCA1 (108). Interestingly, one substitution mutation (W590S), however, reduces apolipoprotein-mediated lipid efflux severely but increased apoA-I binding moderately (105).…”
Section: Resultsmentioning
confidence: 94%
“…The C-terminal VFVNFA motif of ABCA1 has been shown to be essential for its lipid efflux activity. Alteration of this motif did not prevent trafficking of the transporter to the plasma membrane, but did eliminate apoA-I binding to ABCA1 (108). Interestingly, one substitution mutation (W590S), however, reduces apolipoprotein-mediated lipid efflux severely but increased apoA-I binding moderately (105).…”
Section: Resultsmentioning
confidence: 94%
“…Therefore, we assessed the mRNA levels of the cholesterol efflux transporter ATP-binding cassette 1 (ABCA1), which regulates the rate-controlling step in the removal of cellular cholesterol by transferring cholesterol and phospholipids to an apolipoprotein acceptor (Fitzgerald et al 2004). Mutations in ABCA1, as seen in Tangier disease, result in accumulation of cellular cholesterol (Bodzioch et al 1999).…”
Section: Resultsmentioning
confidence: 99%
“…These results suggest that segments of ABCA4 downstream of the VFVNFA motif enhance the basal ATPase activity of ABCA4 and ABCA1, whereas segments of ABCA1 downstream of this motif reduce the basal ATPase activity of these transporters. The basal activities, however, do not appear to reflect the true function of these transporters, since the ABCA1-⌬46 mutant has been reported to be defective in cholesterol efflux (28).…”
Section: Differential Effect Of C-terminal Deletion and Chimera Mutatmentioning
confidence: 99%